A restriction endonuclease that recognizes the sequence GT_^AC and 2 more items

New England Biolabs Inc was awarded contract A207_PO-0444055-V3 by the University of Virginia on August 8, 2026, with a cumulative contract value of $366. The contract calls for the delivery of molecular biology reagents and enzymes to support research activities. The deliverables include three distinct line items: 68 units of a restriction endonuclease recognizing the GT_^AC sequence at $1 per unit, 70 units of a restriction endonuclease recognizing the G^ANT_C sequence at $1 per unit, and 228 units of phi29 DNA Polymerase at $1 per unit.

The phi29 DNA Polymerase specified in the contract is the replicative polymerase derived from Bacillus subtilis phage phi29, selected for its exceptional strand displacement and processive synthesis properties, as well as its inherent 3' to 5' proofreading exonuclease activity. All deliverables are designated for delivery to the University of Virginia as the contracting organization and buyer. The restriction endonucleases and phi29 DNA Polymerase are specialized molecular biology tools commonly utilized in DNA amplification, cloning, and analytical applications within academic research environments.